These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2670217)

  • 1. Clinical pharmacology of ACE inhibition.
    Nussberger J; Waeber B; Brunner HR
    Cardiology; 1989; 76 Suppl 2():11-22. PubMed ID: 2670217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma angiotensin II and the antihypertensive action of angiotensin-converting enzyme inhibition.
    Nussberger J; Waeber B; Brunner HR
    Am J Hypertens; 1989 Apr; 2(4):286-93. PubMed ID: 2650711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors, angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists: relationships between blood pressure responses and effects on the renin-angiotensin system.
    Schalekamp MA; Derkx FH; van den Meiracker AH
    J Hypertens Suppl; 1992 Dec; 10(7):S157-64. PubMed ID: 1291650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Do kinins have significance for the antihypertensive effect of angiotensin-converting enzyme inhibitors?].
    Bönner G
    Z Kardiol; 1988; 77 Suppl 3():23-7. PubMed ID: 3062958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    J Hypertens Suppl; 1993 Apr; 11(3):S53-8. PubMed ID: 8315521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin system: is direct renin inhibition different from blockade at the AT1 receptor or the ACE step?
    Hollenberg NK
    Rev Cardiovasc Med; 2007; 8 Suppl 2():S7-13. PubMed ID: 17401314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What we would like to know about the antihypertensive mechanisms of angiotensin converting enzyme inhibition.
    Brunner HR; Waeber B; Nussberger J
    J Hypertens Suppl; 1988 Dec; 6(3):S1-5. PubMed ID: 3066876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibition versus blockade of the renin-angiotensin system.
    Brunner HR; Waeber B; Nussberger J
    Am J Med; 1989 Dec; 87(6B):15S-18S. PubMed ID: 2690609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the renin--angiotensin system on the vessel wall: using ACE inhibition to improve endothelial function.
    Neutel JM
    J Hum Hypertens; 2004 Sep; 18(9):599-606. PubMed ID: 15190263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present aspects and future developments with ACE inhibitors.
    Reid JL
    Cardiology; 1989; 76 Suppl 2():1-10. PubMed ID: 2670216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin II antagonists versus ACE inhibitors in the treatment of raised blood pressure].
    Andersen RS; Christensen S
    Ugeskr Laeger; 2001 Dec; 163(50):7036-9. PubMed ID: 11794033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertensive mechanisms and converting enzyme inhibitors.
    Ferrario CM; Jaiswal N; Yamamoto K; Diz DI; Schiavone MT
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV56-62; discussion IV83-90. PubMed ID: 1893643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.